Emergency Medicine Doctors in Newport, TN Accepting Medicare

5 Emergency Medicine doctors found. Showing 1 - 5

Constantino Diaz Miranda, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 435 2nd Street, Newport, TN 37821 Phone: 423-625-2200

Travis Fawver, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 2nd St, Newport, TN 37821 Phone: 423-625-2200

Dr. Wayne Berry Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 4th St, Newport, TN 37821 Phone: 423-623-6240    Fax: 423-623-0102

David L Shumway, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 435 2nd St, Newport, TN 37821 Phone: 800-577-7707    Fax: 865-769-3476

Frank Werderitch, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 435 2nd St, Newport, TN 37821 Phone: 423-625-2200

News Archive

ACR REF Clinician Scholar Education Award for rheumatology health professionals

At the core of the American College of Rheumatology Research and Education Foundation's mission is to attract the best and brightest trainees into a career in rheumatology. To do this, the REF has an extensive portfolio of awards and grants that provide support during critical career stages.

Discovery could open door to the development of new anti-cancer drugs

A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.

Inherited mutations in p53 gene put people at high risk of developing cancers

The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.

New Zealand to trial pig cells as treatment for type 1 diabetes

Authorities in New Zealand have given conditional approval for a human trial to go ahead using pig cells to treat type 1 diabetes.

Novo Nordisk in-licenses intellectual property rights to IL-21 antibodies

Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.

Read more Medical News

› Verified 5 days ago